Stockscreener 앱 받기
0.5925
1.84%
0.0107
전일 마감가:
$0.5818
열려 있는:
$0.6
하루 거래량:
18,395
Relative Volume:
0.48
시가총액:
$3.45M
수익:
$14.64M
순이익/손실:
$-13.74M
주가수익비율:
-0.0815
EPS:
-7.27
순현금흐름:
$-5.04M
1주 성능:
-0.17%
1개월 성능:
-10.55%
6개월 성능:
-8.85%
1년 성능:
+55.92%
1일 변동 폭
$0.57
$0.62
1주일 범위
$0.57
$0.62
52주 변동 폭
$0.3611
$1.0099
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
명칭
Novabay Pharmaceuticals Inc
전화
510-899-8800
주소
2000 Powell Street, Suite 1150, Emeryville, CA
NBY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
0.5925 | 3.44M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-09-18 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-06 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 재확인 | Laidlaw | Buy |
| 2017-06-05 | 개시 | ROTH Capital | Buy |
| 2017-03-27 | 개시 | Laidlaw | Buy |
| 2017-02-06 | 개시 | Rodman & Renshaw | Buy |
| 2016-03-07 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-14 | 재확인 | Maxim Group | Buy |
| 2015-04-30 | 재개 | Maxim Group | Buy |
| 2013-03-06 | 개시 | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 개시 | Dawson James | Speculative Buy |
모두보기
Novabay Pharmaceuticals Inc 주식(NBY)의 최신 뉴스
Is now a turning point for NovaBay Pharmaceuticals Inc.Steady Return Plan Based on Data Analysis - Newser
Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attentionFree Weekly Setup With 3x Return Potential - Newser
Can volume confirm reversal in NovaBay Pharmaceuticals Inc.Free Weekly Watchlist of High Movers - Newser
Is NovaBay Pharmaceuticals Inc. stock reversal real or fakeLong Term Stock Planner with Safety Checks - Newser
Using data tools to time your NovaBay Pharmaceuticals Inc. exit3-Year Equity Summary With Setup Insights - Newser
Custom watchlist performance reports with NovaBay Pharmaceuticals Inc.Free Oversold Bounce Stock Play Ideas - Newser
Market reaction to NovaBay Pharmaceuticals Inc.’s recent newsLow Risk Stock Selection Strategy Guide - Newser
Volatility clustering patterns for NovaBay Pharmaceuticals Inc.Portfolio Building Plan and Summary Guide - Newser
Signal strength of NovaBay Pharmaceuticals Inc. stock in tech scannersFree Weekly Return Pick Forecast Reports - Newser
Multi asset correlation models including NovaBay Pharmaceuticals Inc.Free Entry Zone Strategy for Consistent Profit - Newser
How hedge fund analytics apply to NovaBay Pharmaceuticals Inc. stockDaily Swing Candidate Analysis with Chart Patterns - Newser
How to manage a losing position in NovaBay Pharmaceuticals Inc.Portfolio Building Plan and Summary Guide - Newser
How institutional ownership impacts NovaBay Pharmaceuticals Inc. stockProven Trading System with Consistent Gains - Newser
What’s next for NovaBay Pharmaceuticals Inc. stock priceFree Real Trader Watchlist of Hot Stocks - Newser
Order flow analysis tools used on NovaBay Pharmaceuticals Inc.Free Reliable Investment Entry Point Signals - Newser
Using Bollinger Bands to evaluate NovaBay Pharmaceuticals Inc.Short-Term Stock Trend Forecast Guide - Newser
Should you wait for a breakout in NovaBay Pharmaceuticals Inc.Free Oversold Recovery Opportunity Stocks - Newser
Vincerx Pharma (NASDAQ:VINC) vs. NovaBay Pharmaceuticals (NYSE:NBY) Financial Survey - Defense World
Is NovaBay Pharmaceuticals Inc. trending in predictive chart modelsLong Term Equity Screener with Safety Metrics - Newser
Can machine learning forecast NovaBay Pharmaceuticals Inc. recoverySafe Entry Screening with Data Backed Analysis - Newser
Short interest data insights for NovaBay Pharmaceuticals Inc.Free Investment Strategy With Low Risk - Newser
Analyzing recovery setups for NovaBay Pharmaceuticals Inc. investorsWatchlist Generator for Smart Money Signals - Newser
Analyzing NovaBay Pharmaceuticals Inc. with multi timeframe chartsPrice Spike Prediction for Active Traders - Newser
When is the best time to buy NovaBay Pharmaceuticals Inc. stockBuy List With Technical Entry Triggers - Newser
What drives NovaBay Pharmaceuticals Inc. stock priceFree Expert Stock Watchlist - Jammu Links News
Is NovaBay Pharmaceuticals Inc. stock overvalued or undervaluedInvest confidently with daily market forecasts - Jammu Links News
What makes NovaBay Pharmaceuticals Inc. stock price move sharplyGet professional advice for market timing - Jammu Links News
How many analysts rate NovaBay Pharmaceuticals Inc. as a “Buy”Achieve rapid financial growth with expert help - Jammu Links News
Why is NovaBay Pharmaceuticals Inc. stock attracting strong analyst attentionBuild a diversified portfolio for risk management - Jammu Links News
Does NovaBay Pharmaceuticals Inc. stock perform well during market downturnsPhenomenal wealth increase - Jammu Links News
Novabay Pharmaceuticals Inc (NBY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):